Vaxalta

Risk score

57
Large logo of Vaxalta

Headquarters

Flag of CanadaCanada

VaxAlta is presently in the process of creating multiple glycoconjugate vaccines aimed at bacterial pathogens affecting animal health and the safety of human food (refer to our lineup of vaccines in development below). VaxAlta also offers contract services to customers utilizing our exclusive platform technology for the advancement of innovative glycoconjugate vaccines targeting any kind of pathogen (bacteria, virus, parasite, etc.) with a distinct glycan as the target. Throughout our glycoconjugate vaccine workflow, VaxAlta also devises testing frameworks for quality assurance that are accessible to our customers.